U.S. chip giant Nvidia said on Monday it is building Britain’s most powerful supercomputer, which will use artificial intelligence to help researchers solve pressing medical challenges, including those related to COVID-19. GSK and AstraZeneca, which are both involved in coronavirus vaccine research, will be two of the first pharmaceutical companies to harness the power of the machine, Nvidia said. The Cambridge-1 computer, which is expected to come online by the end of the year in Cambridge, east England, will be a NVIDIA DGX SuperPOD system capable of delivering more than 400 petaflops of AI performance, the company said. …read more
Source:: Yahoo Finance
